Anti-Siglec-3/CD33 Antibody (Gemtuzumab-CLM)
Catalog No.
F1441
Anti-Siglec-3/CD33 Antibody (Gemtuzumab-CLM)
Featured Products
Gemtuzumab (Anti-Siglec-3 / CD33) is a monoclonal antibody against the CD33 antigen, which is present on leukemic myeloblasts in acute myeloid leukemia (AML). It can be used for the study of acute myeloid leukemia. MW: 145.22 KD.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
145.22 kDa
Dry ice
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
gemtuzumab-CLM
100 mM Pro 20 mM Arg pH 5.0. No preservative!
P20138
Human
CLM
Monoclonal
Protein A
IgG4SP
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human CD33 His at 2 ug/mL can bind Anti-Siglec-3/CD33 Antibody (Gemtuzumab-CLM)
Siglec-3 / CD33
Please avoid freeze-thaw cycles.